| Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer FJ Couch, SN Hart, P Sharma, AE Toland, X Wang, P Miron, JE Olson, ... Journal of Clinical Oncology 33 (4), 304-311, 2015 | 750 | 2015 |
| Abstract P5-13-03: Fulvestrant plus anastrozole as neoadjuvant therapy in postmenopausal women with hormone receptor positive early breast cancer QJ Khan, JA Barr, AS Britt, BF Kimler, CS Connor, M McGinness, ... Cancer Research 76 (4 Supplement), P5-13-03-P5-13-03, 2016 | 582* | 2016 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... JAMA 313 (13), 1347-1361, 2015 | 577 | 2015 |
| Genome-wide association studies identify four ER negative-specific breast cancer risk loci M Garcia-Closas, FJ Couch, S Lindstrom, K Michailidou, MK Schmidt, ... Nature genetics 45 (4), 392-398, 2013 | 479 | 2013 |
| Biology and Management of Patients With Triple-Negative Breast Cancer P Sharma The Oncologist, theoncologist. 2016-0067, 2016 | 331 | 2016 |
| Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer QJ Khan, PS Reddy, BF Kimler, P Sharma, SE Baxa, AP O’Dea, JR Klemp, ... Breast cancer research and treatment 119 (1), 111-118, 2010 | 250 | 2010 |
| Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer KS Purrington, S Slager, D Eccles, D Yannoukakos, PA Fasching, P Miron, ... Carcinogenesis 35 (5), 1012-1019, 2014 | 218 | 2014 |
| Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing P Sharma, JR Klemp, BF Kimler, JD Mahnken, LJ Geier, QJ Khan, M Elia, ... Breast cancer research and treatment 145 (3), 707-714, 2014 | 212 | 2014 |
| Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ... Breast Cancer Research 18 (1), 1, 2016 | 148 | 2016 |
| Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts P Sharma, S López-Tarruella, JA García-Saenz, C Ward, C Connor, ... Clinical Cancer Research, clincanres. 0162.2016, 2016 | 143 | 2016 |
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer FJ Couch, KB Kuchenbaecker, K Michailidou, GA Mendoza-Fandino, ... Nature communications 7, 2016 | 135 | 2016 |
| 19p13. 1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus KN Stevens, Z Fredericksen, CM Vachon, X Wang, S Margolin, ... Cancer research 72 (7), 1795-1803, 2012 | 134 | 2012 |
| The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer P Sharma, SR Stecklein, BF Kimler, G Sethi, BK Petroff, TA Phillips, ... Journal of cancer therapeutics & research 3 (2), 1, 2014 | 75 | 2014 |
| Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside CJ Fabian, BF Kimler, CM Zalles, JR Klemp, BK Petroff, QJ Khan, ... Cancer Prevention Research 3 (10), 1342-1350, 2010 | 65 | 2010 |
| Musculoskeletal adverse events associated with adjuvant aromatase inhibitors QJ Khan, AP O'Dea, P Sharma Journal of oncology 2010, 2010 | 60 | 2010 |
| Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high … QJ Khan, BF Kimler, AP O'Dea, CM Zalles, P Sharma, CJ Fabian Breast Cancer Res 9 (3), R35, 2007 | 45 | 2007 |
| Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells W Fiskus, SL Hembruff, R Rao, P Sharma, R Balusu, S Venkannagari, ... Breast cancer research and treatment 135 (2), 433-444, 2012 | 36 | 2012 |
| Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letrozole: The VITAL trial QJ Khan, BF Kimler, PS Reddy, P Sharma, JR Klemp, CJ Fabian J Clin Oncol 30 (suppl), abstr 9000, 2012 | 31 | 2012 |
| Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens P Sharma, JR Klemp, M Simonsen, CM Welsko, CM Zalles, BF Kimler, ... Breast cancer research and treatment 87 (1), 59-64, 2004 | 29 | 2004 |
| Abstract P1-11-07: results of a Phase II study of neoadjuvant platinum/taxane based chemotherapy and erlotinib for triple negative breast cancer P Sharma, QJ Khan, BF Kimler, JR Klemp, CJ Connor, MK McGinness, ... Cancer Research 70 (24 Supplement), P1-11-07-P1-11-07, 2010 | 27 | 2010 |
